Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases

Detalles Bibliográficos
Autores principales: Chan, Eugene Yu-Hin, Leung, Daniel, Cheng, Samuel M.S., Rosa Duque, Jaime S., Mu, Xiaofeng, Ho, Fanny Tsz-Wai, Tong, Pak-Chiu, Lai, Wai-Ming, Lee, Matthew H.L., Chim, Stella, Tam, Issan Y.S., Tsang, Leo C.H., Kwan, Kelvin K.H., Chung, Yuet, Wong, Howard H.W., Lee, Amos M.T., Li, Wing Yan, Sze, Summer T.K., Lam, Jennifer H.Y., Lee, Derek H.L., Chan, Sau Man, Tu, Wenwei, Peiris, Malik, Ma, Alison Lap-Tak, Lau, Yu Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577489/
https://www.ncbi.nlm.nih.gov/pubmed/37850008
http://dx.doi.org/10.1016/j.ekir.2023.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577489/
https://www.ncbi.nlm.nih.gov/pubmed/37850008
http://dx.doi.org/10.1016/j.ekir.2023.08.012

Ejemplares similares